The regulatory role of peripheral blood mononuclear cell function by A20


  • Nguyen Thi Xuan "Institute of Genome Research, Vietnam Academy of Science and Technology"
  • Nguyen Huy Hoang "Institute of Genome Research, Vietnam Academy of Science and Technology"



A20, apoptosis, cytokine, migration, PBMCs


Peripheral blood mononuclear cells (PBMC) consist of lymphocytes (T cells, B cells, natural killer cells), monocytes and dendritic cells and play important roles in initiating and regulating immunity against pathogens or immunotolerance to allergens. Activation of PBMCs is induced upon exposure to multiple stimuli by the binding with toll-like receptors (TLRs), recognition elements of the innate immune system. A20 is a negative regulator of nuclear factor (NF)-κB-dependent immune reaction in response to TLR ligands. A20-deficient mice display severe inflammation, tissue damage in multiple organs, cachexia and premature mortality. Single nucleotide polymorphisms (SNPs) at A20 gene region in humans reduce the binding capacity of A20 to NF‐κB subunits, resulting in reduced expression and function of A20 and leading to the pathogenesis of autoimmune and cancers. Although the inhibitory role of A20 on immune cells including B, T and DC functions has been previously reported, the effect of A20 on PBMC function is not mentioned yet. The present study, therefore, explored whether A20 expression is involved in immunophenotypic changes, the release of cytokine production, cell migration, and apoptosis. To this end, immonophenotypic profile and cell apoptosis were examined by flow cytometry, secretion of inflammatory cytokines by ELISA and cell migration by a transwell migration assay. As a result, percentages of CD3+CD25+, CD19+CD25+, and CD11b+CD40+ expressing cells, the release of TNF-α and IL-1β and cell migration were enhanced in A20-silenced PBMCs. However, cell apoptosis was independent of the presence of A20 in PBMCs. In conclusion, these results attained in this study suggested that A20 expression might modulate the immune response in autoimmune disease and cancers.


Download data is not yet available.


Catrysse L, Vereecke L, Beyaert R, & van Loo G. (2014) A20 in inflammation and autoimmunity. Trends Immunol 35: 22-31.

Chen L, Lei L, Li T, Yan J, & Jiang J. (2018) A20 alleviates the vascular remodeling induced by homocysteine. Am J Transl Res 10: 3991-4003.

De Wilde K, Martens A, Lambrecht S, et al. (2017) A20 inhibition of STAT1 expression in myeloid cells: a novel endogenous regulatory mechanism preventing development of enthesitis. Ann Rheum Dis 76: 585-592.

Duy PN, Thuy NT, Trang BK, et al. (2019) Regulation of NF-kappaB- and STAT1-mediated plasmacytoid dendritic cell functions by A20. PLoS One 14: e0222697.

Fischer JC, Otten V, Kober M, et al. (2017) A20 Restrains Thymic Regulatory T Cell Development. J Immunol 199: 2356-2365.

Hovelmeyer N, Reissig S, Xuan NT, et al. (2011) A20 deficiency in B cells enhances B-cell proliferation and results in the development of autoantibodies. Eur J Immunol 41: 595-601.

Johansson P, Bergmann A, Rahmann S, et al. (2016) Recurrent alterations of TNFAIP3 (A20) in T-cell large granular lymphocytic leukemia. Int J Cancer 138: 121-124.

Kato M, Sanada M, Kato I, et al. (2009) Frequent inactivation of A20 in B-cell lymphomas. Nature 459: 712-716.

Lauer FT, Parvez F, Factor-Litvak P, et al. (2019) Changes in human peripheral blood mononuclear cell (HPBMC) populations and T-cell subsets associated with arsenic and polycyclic aromatic hydrocarbon exposures in a Bangladesh cohort. PLoS One 14: e0220451.

Lee EG, Boone DL, Chai S, et al. (2000) Failure to regulate TNF-induced NF-kappaB and cell death responses in A20-deficient mice. Science 289: 2350-2354.

Li KZ, Liao ZY, Li YX, et al. (2019) A20 rescues hepatocytes from apoptosis through the NF-kappaB signaling pathway in rats with acute liver failure. Biosci Rep 39:

Luczynski W, Stasiak-Barmuta A, Ilendo E, et al. (2006) CD40 stimulation induces differentiation of acute lymphoblastic leukemia cells into dendritic cells. Acta Biochim Pol 53: 377-382.

Shao B, Wei X, Luo M, et al. (2015) Inhibition of A20 expression in tumor microenvironment exerts anti-tumor effect through inducing myeloid-derived suppressor cells apoptosis. Sci Rep 5: 16437.

Shembade N, & Harhaj EW. (2012) Regulation of NF-kappaB signaling by the A20 deubiquitinase. Cell Mol Immunol 9: 123-130.

Simader E, Beer L, Laggner M, et al. (2019) Tissue-regenerative potential of the secretome of gamma-irradiated peripheral blood mononuclear cells is mediated via TNFRSF1B-induced necroptosis. Cell Death Dis 10: 729.

Sun L, Zou LX, Han YC, et al. (2019) A20 overexpression exerts protective effects on podocyte injury in lupus nephritis by downregulating UCH-L1. J Cell Physiol

Wang X, Deckert M, Xuan NT, et al. (2013) Astrocytic A20 ameliorates experimental autoimmune encephalomyelitis by inhibiting NF-kappaB- and STAT1-dependent chemokine production in astrocytes. Acta Neuropathol 126: 711-724.

Xuan NT, Wang X, Nishanth G, et al. (2014) A20 expression in dendritic cells protects mice from LPS-induced mortality. Eur J Immunol

Xuan NT, Wang X, Nishanth G, et al. (2015) A20 expression in dendritic cells protects mice from LPS-induced mortality. Eur J Immunol 45: 818-828.

Zhang F, Yang L, & Li Y. (2012) The role of A20 in the pathogenesis of lymphocytic malignancy. Cancer Cell Int 12: 44.

Zhou Q, Wang H, Schwartz DM, et al. (2016) Loss-of-function mutations in TNFAIP3 leading to A20 haploinsufficiency cause an early-onset autoinflammatory disease. Nat Genet 48: 67-73.